跳至主要内容
临床试验/JPRN-UMIN000006945
JPRN-UMIN000006945已完成未知

Multicenter pahse II trial of neoadjuvant goserelin acetate and tamoxifen treatment for premenopausal ER-positive and HER2-negative breast cancers - ZTNeo trial

Department of Breast and Endocrine Surgery, Hyogo College of Medicine0 个研究点目标入组 100 人开始时间: 2011年12月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 55years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. Another cancer diagnosed within 5 years 2. Pregnant or nursing women 3. Cases who physician judged improper to entry this trial

研究者

发起方
Department of Breast and Endocrine Surgery, Hyogo College of Medicine

相似试验

招募中
1 期
Phase II, multi-cohort trial of neoadjuvant and post-surgery IO102-IO103 and pembrolizumab in patients with selected resectable tumorsMelanoma and squamous cell carcinoma of the head and neckMedDRA version: 20.0Level: LLTClassification code: 10040891Term: Skin melanoma Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10060121Term: Squamous cell carcinoma of head and neck Class: 100000004864
CTIS2022-502787-20-00IO Biotech ApS90
进行中(未招募)
不适用
A multicenter Phase II clinical trial of neoadjuvant trabectedin (Yondelis) in patients with localized myxoid / round cell liposarcoma. - NDocalized myxoid / round cell liposarcoma (MRCL).MedDRA version: 6.1Level: PTClassification code 10024630
EUCTR2007-000035-25-ITPHARMA MAR22
已完成
2 期
Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinomaoral squamous cell carcinoma
JPRN-C000000023Chubu research group on oral cancer30
已完成
2 期
Multicenter phase II trial of neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin for HER2-positive operable breast cancer: KBOG-1204 trialbreast cancer
JPRN-UMIN000010227Kanagawa Breast Oncology Group (KBOG)40
招募中
2 期
Phase II multicenter trial of neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant chemotherapy by irrinotecan hydrochloride and nedaplatin for the patients with stage Ib2-IIb bulky cervical cancer (tumor diameter > 4 cm): OGSK_KCOG-G1201Cervical cancer
JPRN-UMIN000008023The Obstetrical and Gynecological Society of Kinki District Japan and the Kansai Clinical Oncology Group68